The power of Sudoscan’s exclusive patents for neuropathy diagnosis

Sudoscan in the world

SUDOSCAN patented technology enables healthcare professionals to access advanced solutions for neuropathy and sudomotor dysfunction diagnosis.

Discover Sudoscan

Sudoscan in the world

SUDOSCAN : An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.

US website

International

About SUDOSCAN US

SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers

Diabetes

SUDOSCAN provides a better management of diabetes complications such as neuropathies to prevent diabetic foot.

Neurology

SUDOSCAN has demonstrated its efficacy in painful neuropathies, transthyretin amyloidosis, Sjogren’s Syndrome, Hepatitis C, Fabry disease…

Oncology

In oncology, SUDOSCAN has demonstrated its utility to quantify chemotherapy induced polyneuropathy (CIPN).

Nephrology

SUDOSCAN has demonstrated its efficacy in the field of nephrology.

Follow-up

SUDOSCAN allows the physician to follow patient outcomes over time and assess the progression of neuropathy and the impact of medications.

An Innovative Device

SUDOSCAN is a test that provides an accurate evaluation of sweat function.

The test focuses on small nerve fibers within the peripheral nervous system innervating the sweat glands.
The device consists of a computer and 4 electrodes on which patients place their hands and bare feet.
In less than 3 minutes, SUDOSCAN offers a stimulation of the sweat glands that assess small nerve fibers (C fibers).

Simple Results Obtained in 3 Minutes

The results are displayed automatically.

The patient is asked to put his hands and feet on large electrodes.
A small electric tension is applied to the surface to stimulate the sweat glands.
The results of the response to this stimulation are expressed as: Electrochemical Skin Conductance for SUDOSCAN, indicating the presence and severity of the small fiber peripheral autonomic neuropathies.

If the score is high, this indicates no sign of sudomotor dysfunction and no autonomic neuropathy.

If the score is low, this indicates a sudomotor dysfunction and a neuropathy.

Scientific references across the World

SUDOSCAN has been cited, evaluated or used in scientific publications involving hospitals, universities and research centers across multiple countries.

306 institutions / research centers

45 countries

185+ cities

208 PubMed references

Discover Sudoscan scientific references

Clinical Evidence for SUDOSCAN

SUDOSCAN Is Becoming a Reference Test in Many Countries.

Commercialized worldwide with more than 5000 devices sold.

CE certified Cleared for use by the US FDA, Registered and distributed in 34 countries Included the European Network for TTR-FAP Amyloidosis, The German guidelines for Diabetes management, The Latin America Diabetes association, And more…

You can discover our Sudoscan publications in many areas such as :

Small fiber neuropathy SUDOSCAN reliability
Diabetes complications
Amyloidosis Sjörgen’s Syndrome Fabry disease Parkinson’s disease
Chemo induced peripheral neuropathy
Treatment Follow-up Lifestyle impact

Discover Sudoscan publication

For us to improve nerve function and the quality of life of the individual, we had to do extensive measures: skin biopsy to look at nerve regeneration, nerve conduction studies to show enhancements of nerve conductions and quantitative sensory tests which have a wide variance. These tests are time consuming, laborious and full of error. Now, we have SUDOSCAN that can measure electrical conductance along with sweat gland function in only 2 minutes with instant results that are 75% sensitive, 98% specific and with less than 5% error*.”*Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new tool to detect diabetes risk. Br J Diabetes Vasc Dis 11:204-209.

Aaron I. Vinik, MD, PhD, FCP, MACP, FACE, Your Content Goes Here